RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Income before tax

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndIncome before tax (Million USD)YoY (%)
Dec 31, 2024-1,284+105.77%
Dec 31, 2023-624-79.64%
Dec 31, 2022-3,065-565.81%
Dec 31, 2021658-114.93%
Dec 31, 2020-4,406+248.30%
Dec 31, 2019-1,265-51.27%
Dec 31, 2018-2,596-85.88%
Dec 31, 2017-18,379-2330.46%
Dec 31, 2016824-64.97%
Dec 31, 20152,352-35.35%
Dec 31, 20143,638+191.04%
Dec 31, 20131,250-31.28%
Dec 31, 20121,819-38.46%
Dec 31, 20112,956-18.92%
Dec 31, 20103,646

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)